Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market is segmented by Test Type (Blood Biomarker Tests, Imaging Tests including CT, MRI, and Ultrasound, Tissue Biopsy, Liquid Biopsy, and Molecular Diagnostics), Cancer Type (Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, and Others including metastatic liver cancer and rare hepatic tumors), End Use (Hospitals and Diagnostic Centers, Cancer Research Institutes, Pathology Labs, and Others), and Region. Forecast for 2026 to 2036.